{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028429","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2026-06-12T20:05:55+00:00","discovered_at":"2026-06-12T20:08:00.291702+00:00","generated_at":"2026-06-12T20:17:13.547103+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Lipocine hosts KOL event for postpartum depression drug LPCN 1154","bullets":["Virtual key opinion leader event held on June 12, 2026.","Event highlighted unmet needs in postpartum depression and clinical profile of LPCN 1154.","Presentation slides available on corporate website; no new clinical data disclosed in the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028429","json":"https://secwatch.observer/filing/0001493152-26-028429.json","markdown":"https://secwatch.observer/filing/0001493152-26-028429.md","text":"https://secwatch.observer/filing/0001493152-26-028429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226028429/0001493152-26-028429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226028429/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:17:13.547103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}